The decline of venture capital investment in early-stage life sciences poses a challenge to continued innovation. [electronic resource]
Producer: 20161213Description: 271-6 p. digitalISSN:- 2694-233X
- Biological Science Disciplines -- economics
- Capital Financing -- trends
- Drug Approval -- economics
- Health Policy -- economics
- Humans
- Investments -- economics
- Orphan Drug Production -- economics
- Private Sector -- economics
- Reimbursement, Incentive -- economics
- Translational Research, Biomedical -- economics
- United States
- United States Food and Drug Administration -- standards
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.